Bionexus Gene Lab Corp (BGLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,584 | 2,624 | 612 | 579 | 700 |
| Marketable Securities | 2,794 | 3,305 | 1,507 | 1,545 | 2,088 |
| Receivables | 1,664 | 980 | 2,925 | 3,436 | 4,022 |
| Inventories | 1,389 | 1,138 | 978 | 1,522 | 1,176 |
| Other current assets | 0 | 0 | 0 | 68 | 0 |
| TOTAL | $7,430 | $8,047 | $6,022 | $7,150 | $7,986 |
| Non-Current Assets | |||||
| PPE Net | 1,523 | 1,512 | 1,512 | 1,634 | 1,786 |
| Investments And Advances | 1,265 | 1,700 | 1,151 | 749 | 282 |
| Other Non-Current Assets | 215 | 142 | 56 | 41 | 63 |
| TOTAL | $3,003 | $3,353 | $2,718 | $2,425 | $2,130 |
| Total Assets | $10,434 | $11,400 | $8,740 | $9,574 | $10,115 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,787 | 1,583 | 1,964 | 2,084 | 3,267 |
| Other current liabilities | 17 | 13 | N/A | N/A | N/A |
| TOTAL | $1,951 | $1,631 | $2,004 | $2,329 | $3,374 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 77 | N/A |
| Other Non-Current Liabilities | 160 | 99 | 40 | 25 | 42 |
| TOTAL | $160 | $111 | $71 | $66 | $80 |
| Total Liabilities | $2,111 | $1,742 | $2,075 | $2,395 | $3,453 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,968 | 1,767 | 1,447 | 1,426 | 1,426 |
| Common Shares | 17,332 | 17,191 | 10,930 | 10,780 | 10,780 |
| Retained earnings | -3,443 | -1,844 | 1,156 | 1,512 | 761 |
| Other shareholders' equity | -555 | -677 | -409 | -100 | 134 |
| TOTAL | $8,323 | $9,658 | $6,665 | $7,180 | $6,662 |
| Total Liabilities And Equity | $10,434 | $11,400 | $8,740 | $9,574 | $10,115 |